vadadustat
HSC-MS-20-0395
Phase 2 small_molecule completed
Quick answer
vadadustat for Acute Respiratory Distress Syndrome is a Phase 2 program (small_molecule) at Akebia Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Akebia Therapeutics
- Indication
- Acute Respiratory Distress Syndrome
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed